Mainstream

Metsera ultra-long acting GLP-1 MET-097i excels in mid-stage trial

Metsera ultra-long acting GLP-1 MET-097i excels in mid-stage trial

Post Contentmtsr, pfeRead More

You might also be interested in reading Cryptocurrency investors eagerly awaiting SEC ruling on bitcoin ETFs.

September 29, 2025
In Mainstream